Figure 2
From: CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis
(A) Immunohistochemical staining of hepatic CCN1 in human livers from healthy controls and patients with NASH (400×). (B) Statistics of hepatic CCN1 expression in patients with NASH and healthy controls. (C) Hepatic CCN1 was positively associated with the NAFLD activity score (r = 0.64, p = 0.0013). (D) Hepatic CCN1 was positively associated with steatosis (r = 0.56, p = 0.0068). ***P < 0.001.
